{"id":7603,"date":"2024-07-23T10:26:17","date_gmt":"2024-07-23T09:26:17","guid":{"rendered":"https:\/\/els-solutions.com\/cms\/dev\/?p=7603"},"modified":"2024-07-23T10:26:17","modified_gmt":"2024-07-23T09:26:17","slug":"infarmed-approves-new-acm-cannabis-preparations","status":"publish","type":"post","link":"https:\/\/els-solutions.com\/en\/infarmed-approves-new-acm-cannabis-preparations\/","title":{"rendered":"Infarmed approves two new ACMs for cannabis formulas"},"content":{"rendered":"<\/p>\n<p style=\"text-align: center;\"><strong>Infarmed approves two new ACMs for cannabis formulas<\/strong><\/p>\n<p style=\"text-align: center;\">Infarmed (Portugal&#8217;s regulatory body) has approved two new preparations based on medicinal cannabis: Satalliv (THC) and Tilray (THC10 CBD10). With this, Portugal now has six options available, including Sativex and Epidyolex. Pharmacies will soon receive these oral solutions on prescription, expanding the therapeutic indications. <a href=\"https:\/\/cannareporter.eu\/en\/2024\/07\/18\/infarmed-aprova-duas-novas-acms-de-preparacoes-a-base-de-canabis\/\" target=\"_blank\" rel=\"noopener\"><span class=\" author-d-iz88z86z86za0dz67zz78zz78zz74zz68zjz80zz71z9iz90z9z84zmz66zz71znz68znz69zz87z3z89zhz65zz89zybhz84zz79zkwtz79zsz76zdz122zjz80z7\">Read more here<\/span><\/a><\/p>\n<p style=\"text-align: center;\">If you need more information on cannabis regulatory issues, ELS can certainly help.<\/p>\n<p style=\"text-align: center;\"><span class=\" author-d-iz88z86z86za0dz67zz78zz78zz74zz68zjz80zz71z9iz90z9z84zmz66zz71znz68znz69zz87z3z89zhz65zz89zybhz84zz79zkwtz79zsz76zdz122zjz80z7\">Please do not hesitate to c<\/span>ontact your <a href=\"https:\/\/els-solutions.com\/onde-estamos\/\" target=\"_blank\" rel=\"noopener\">local ELS consultant<\/a>\u00a0or via email info@elssolutions.pt<\/p>\n<p>\n","protected":false},"excerpt":{"rendered":"<p>Infarmed approves Satalliv and Tilray and increases the number of medicinal cannabis preparations available in Portugal to six.<\/p>\n","protected":false},"author":9,"featured_media":7597,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_joinchat":[],"footnotes":""},"categories":[54,61],"tags":[62],"class_list":["post-7603","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-general","category-news","tag-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Infarmed approves two new ACMs for cannabis preparations<\/title>\n<meta name=\"description\" content=\"Infarmed approves Satalliv and Tilray and increases the number of medicinal cannabis preparations available in Portugal to six.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/els-solutions.com\/en\/infarmed-approves-new-acm-cannabis-preparations\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Infarmed approves two new ACMs for cannabis preparations\" \/>\n<meta property=\"og:description\" content=\"Infarmed approves Satalliv and Tilray and increases the number of medicinal cannabis preparations available in Portugal to six.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/els-solutions.com\/en\/infarmed-approves-new-acm-cannabis-preparations\/\" \/>\n<meta property=\"og:site_name\" content=\"ELS Group - Accelerating Innovation\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/els.solutions\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-07-23T09:26:17+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2024\/07\/ELS-Solutions-INFARMED-approved-medicinal-canabis-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"600\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Marketing ELS\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Marketing ELS\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/els-solutions.com\/en\/infarmed-approves-new-acm-cannabis-preparations\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/els-solutions.com\/en\/infarmed-approves-new-acm-cannabis-preparations\/\"},\"author\":{\"name\":\"Marketing ELS\",\"@id\":\"https:\/\/els-solutions.com\/en\/#\/schema\/person\/9fb8dae537039679cfc537a000df6ca3\"},\"headline\":\"Infarmed approves two new ACMs for cannabis formulas\",\"datePublished\":\"2024-07-23T09:26:17+00:00\",\"dateModified\":\"2024-07-23T09:26:17+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/els-solutions.com\/en\/infarmed-approves-new-acm-cannabis-preparations\/\"},\"wordCount\":815,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/els-solutions.com\/en\/#organization\"},\"image\":{\"@id\":\"https:\/\/els-solutions.com\/en\/infarmed-approves-new-acm-cannabis-preparations\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2024\/07\/ELS-Solutions-INFARMED-approved-medicinal-canabis-1.jpg\",\"keywords\":[\"News\"],\"articleSection\":[\"General\",\"News\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/els-solutions.com\/en\/infarmed-approves-new-acm-cannabis-preparations\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/els-solutions.com\/en\/infarmed-approves-new-acm-cannabis-preparations\/\",\"url\":\"https:\/\/els-solutions.com\/en\/infarmed-approves-new-acm-cannabis-preparations\/\",\"name\":\"Infarmed approves two new ACMs for cannabis preparations\",\"isPartOf\":{\"@id\":\"https:\/\/els-solutions.com\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/els-solutions.com\/en\/infarmed-approves-new-acm-cannabis-preparations\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/els-solutions.com\/en\/infarmed-approves-new-acm-cannabis-preparations\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2024\/07\/ELS-Solutions-INFARMED-approved-medicinal-canabis-1.jpg\",\"datePublished\":\"2024-07-23T09:26:17+00:00\",\"dateModified\":\"2024-07-23T09:26:17+00:00\",\"description\":\"Infarmed approves Satalliv and Tilray and increases the number of medicinal cannabis preparations available in Portugal to six.\",\"breadcrumb\":{\"@id\":\"https:\/\/els-solutions.com\/en\/infarmed-approves-new-acm-cannabis-preparations\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/els-solutions.com\/en\/infarmed-approves-new-acm-cannabis-preparations\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/els-solutions.com\/en\/infarmed-approves-new-acm-cannabis-preparations\/#primaryimage\",\"url\":\"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2024\/07\/ELS-Solutions-INFARMED-approved-medicinal-canabis-1.jpg\",\"contentUrl\":\"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2024\/07\/ELS-Solutions-INFARMED-approved-medicinal-canabis-1.jpg\",\"width\":1200,\"height\":600,\"caption\":\"cannabis medicinal que passa a estar dispon\u00edvel em Portugal\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/els-solutions.com\/en\/infarmed-approves-new-acm-cannabis-preparations\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\/\/els-solutions.com\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Infarmed approves two new ACMs for cannabis formulas\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/els-solutions.com\/en\/#website\",\"url\":\"https:\/\/els-solutions.com\/en\/\",\"name\":\"ELS Group - Accelerating Innovation\",\"description\":\"Assessoria estrat\u00e9gia para a Ind\u00fastria Farmac\u00eautica\",\"publisher\":{\"@id\":\"https:\/\/els-solutions.com\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/els-solutions.com\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/els-solutions.com\/en\/#organization\",\"name\":\"ELS Group - Accelerating Innovation\",\"url\":\"https:\/\/els-solutions.com\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/els-solutions.com\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2023\/08\/ELS-NewLogo-ColorBlack-1-e1691153715735.png\",\"contentUrl\":\"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2023\/08\/ELS-NewLogo-ColorBlack-1-e1691153715735.png\",\"width\":2226,\"height\":1080,\"caption\":\"ELS Group - Accelerating Innovation\"},\"image\":{\"@id\":\"https:\/\/els-solutions.com\/en\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/els.solutions\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/els-solutions.com\/en\/#\/schema\/person\/9fb8dae537039679cfc537a000df6ca3\",\"name\":\"Marketing ELS\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/els-solutions.com\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/b785df1d10c9806cc43fcea2dbf585b96a8761ff697010979d603fc5b7a9ca7b?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/b785df1d10c9806cc43fcea2dbf585b96a8761ff697010979d603fc5b7a9ca7b?s=96&d=mm&r=g\",\"caption\":\"Marketing ELS\"},\"sameAs\":[\"https:\/\/els-solutions.com\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Infarmed approves two new ACMs for cannabis preparations","description":"Infarmed approves Satalliv and Tilray and increases the number of medicinal cannabis preparations available in Portugal to six.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/els-solutions.com\/en\/infarmed-approves-new-acm-cannabis-preparations\/","og_locale":"en_US","og_type":"article","og_title":"Infarmed approves two new ACMs for cannabis preparations","og_description":"Infarmed approves Satalliv and Tilray and increases the number of medicinal cannabis preparations available in Portugal to six.","og_url":"https:\/\/els-solutions.com\/en\/infarmed-approves-new-acm-cannabis-preparations\/","og_site_name":"ELS Group - Accelerating Innovation","article_publisher":"https:\/\/www.facebook.com\/els.solutions\/","article_published_time":"2024-07-23T09:26:17+00:00","og_image":[{"width":1200,"height":600,"url":"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2024\/07\/ELS-Solutions-INFARMED-approved-medicinal-canabis-1.jpg","type":"image\/jpeg"}],"author":"Marketing ELS","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Marketing ELS","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/els-solutions.com\/en\/infarmed-approves-new-acm-cannabis-preparations\/#article","isPartOf":{"@id":"https:\/\/els-solutions.com\/en\/infarmed-approves-new-acm-cannabis-preparations\/"},"author":{"name":"Marketing ELS","@id":"https:\/\/els-solutions.com\/en\/#\/schema\/person\/9fb8dae537039679cfc537a000df6ca3"},"headline":"Infarmed approves two new ACMs for cannabis formulas","datePublished":"2024-07-23T09:26:17+00:00","dateModified":"2024-07-23T09:26:17+00:00","mainEntityOfPage":{"@id":"https:\/\/els-solutions.com\/en\/infarmed-approves-new-acm-cannabis-preparations\/"},"wordCount":815,"commentCount":0,"publisher":{"@id":"https:\/\/els-solutions.com\/en\/#organization"},"image":{"@id":"https:\/\/els-solutions.com\/en\/infarmed-approves-new-acm-cannabis-preparations\/#primaryimage"},"thumbnailUrl":"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2024\/07\/ELS-Solutions-INFARMED-approved-medicinal-canabis-1.jpg","keywords":["News"],"articleSection":["General","News"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/els-solutions.com\/en\/infarmed-approves-new-acm-cannabis-preparations\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/els-solutions.com\/en\/infarmed-approves-new-acm-cannabis-preparations\/","url":"https:\/\/els-solutions.com\/en\/infarmed-approves-new-acm-cannabis-preparations\/","name":"Infarmed approves two new ACMs for cannabis preparations","isPartOf":{"@id":"https:\/\/els-solutions.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/els-solutions.com\/en\/infarmed-approves-new-acm-cannabis-preparations\/#primaryimage"},"image":{"@id":"https:\/\/els-solutions.com\/en\/infarmed-approves-new-acm-cannabis-preparations\/#primaryimage"},"thumbnailUrl":"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2024\/07\/ELS-Solutions-INFARMED-approved-medicinal-canabis-1.jpg","datePublished":"2024-07-23T09:26:17+00:00","dateModified":"2024-07-23T09:26:17+00:00","description":"Infarmed approves Satalliv and Tilray and increases the number of medicinal cannabis preparations available in Portugal to six.","breadcrumb":{"@id":"https:\/\/els-solutions.com\/en\/infarmed-approves-new-acm-cannabis-preparations\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/els-solutions.com\/en\/infarmed-approves-new-acm-cannabis-preparations\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/els-solutions.com\/en\/infarmed-approves-new-acm-cannabis-preparations\/#primaryimage","url":"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2024\/07\/ELS-Solutions-INFARMED-approved-medicinal-canabis-1.jpg","contentUrl":"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2024\/07\/ELS-Solutions-INFARMED-approved-medicinal-canabis-1.jpg","width":1200,"height":600,"caption":"cannabis medicinal que passa a estar dispon\u00edvel em Portugal"},{"@type":"BreadcrumbList","@id":"https:\/\/els-solutions.com\/en\/infarmed-approves-new-acm-cannabis-preparations\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/els-solutions.com\/en\/"},{"@type":"ListItem","position":2,"name":"Infarmed approves two new ACMs for cannabis formulas"}]},{"@type":"WebSite","@id":"https:\/\/els-solutions.com\/en\/#website","url":"https:\/\/els-solutions.com\/en\/","name":"ELS Group - Accelerating Innovation","description":"Assessoria estrat\u00e9gia para a Ind\u00fastria Farmac\u00eautica","publisher":{"@id":"https:\/\/els-solutions.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/els-solutions.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/els-solutions.com\/en\/#organization","name":"ELS Group - Accelerating Innovation","url":"https:\/\/els-solutions.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/els-solutions.com\/en\/#\/schema\/logo\/image\/","url":"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2023\/08\/ELS-NewLogo-ColorBlack-1-e1691153715735.png","contentUrl":"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2023\/08\/ELS-NewLogo-ColorBlack-1-e1691153715735.png","width":2226,"height":1080,"caption":"ELS Group - Accelerating Innovation"},"image":{"@id":"https:\/\/els-solutions.com\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/els.solutions\/"]},{"@type":"Person","@id":"https:\/\/els-solutions.com\/en\/#\/schema\/person\/9fb8dae537039679cfc537a000df6ca3","name":"Marketing ELS","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/els-solutions.com\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/b785df1d10c9806cc43fcea2dbf585b96a8761ff697010979d603fc5b7a9ca7b?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/b785df1d10c9806cc43fcea2dbf585b96a8761ff697010979d603fc5b7a9ca7b?s=96&d=mm&r=g","caption":"Marketing ELS"},"sameAs":["https:\/\/els-solutions.com\/"]}]}},"_links":{"self":[{"href":"https:\/\/els-solutions.com\/en\/wp-json\/wp\/v2\/posts\/7603","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/els-solutions.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/els-solutions.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/els-solutions.com\/en\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/els-solutions.com\/en\/wp-json\/wp\/v2\/comments?post=7603"}],"version-history":[{"count":1,"href":"https:\/\/els-solutions.com\/en\/wp-json\/wp\/v2\/posts\/7603\/revisions"}],"predecessor-version":[{"id":7605,"href":"https:\/\/els-solutions.com\/en\/wp-json\/wp\/v2\/posts\/7603\/revisions\/7605"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/els-solutions.com\/en\/wp-json\/wp\/v2\/media\/7597"}],"wp:attachment":[{"href":"https:\/\/els-solutions.com\/en\/wp-json\/wp\/v2\/media?parent=7603"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/els-solutions.com\/en\/wp-json\/wp\/v2\/categories?post=7603"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/els-solutions.com\/en\/wp-json\/wp\/v2\/tags?post=7603"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}